ebomi
The catalogIssuersInsidersTapeLicence
Colour theme
Theme
Sign in
Insider · CIK 0001619294

Woiwode Thomas

CIK 0001619294 Name as filed on the most recent filing

Filed as Woiwode Thomas (15)

45 transaction lines · from 15 filings · filed 2016-07-25 to 2022-05-03 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

44 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2022-04-29 Tempest Therapeutics, Inc.
TPST 		P, Open-market purchase 2,118,644 acquired 2.36 4,999,999.84 Form 4, filing 0000899243-22-016387
2020-12-30 Gritstone Oncology, Inc.
GRTS 		P, Open-market purchase 1,347,709 acquired 3.71 5,000,000.39 Form 4, filing 0000899243-21-000160
2020-10-20 Aligos Therapeutics, Inc.
ALGS 		P, Open-market purchase 200,000 acquired 15.00 3,000,000.00 Form 4, filing 0001567619-20-018012
2020-03-03 Passage BIO, Inc.
PASG 		P, Open-market purchase 225,000 acquired 18.00 4,050,000.00 Form 4, filing 0001209191-20-015661
2020-03-03 Passage BIO, Inc.
PASG 		P, Open-market purchase 225,000 acquired 18.00 4,050,000.00 Form 4, filing 0001209191-20-015670
2018-05-15 Crispr Therapeutics AG
CRSP 		S, Open-market sale 43,000 disposed 57.97 2,492,710.00 Form 4, filing 0000899243-18-013239
2018-05-15 Crispr Therapeutics AG
CRSP 		S, Open-market sale 1,000 disposed 58.73 58,730.00 Form 4, filing 0000899243-18-013239
2018-05-08 Crispr Therapeutics AG
CRSP 		S, Open-market sale 1,653 disposed 51.45 85,046.85 Form 4, filing 0000899243-18-012101
2018-05-07 Crispr Therapeutics AG
CRSP 		S, Open-market sale 97,550 disposed 50.31 4,907,740.50 Form 4, filing 0000899243-18-012101
2018-05-07 Crispr Therapeutics AG
CRSP 		S, Open-market sale 7,645 disposed 51.26 391,882.70 Form 4, filing 0000899243-18-012101
2018-05-07 Crispr Therapeutics AG
CRSP 		S, Open-market sale 7,424 disposed 50.31 373,501.44 Form 4, filing 0000899243-18-012101
2018-05-07 Crispr Therapeutics AG
CRSP 		S, Open-market sale 3,172 disposed 50.31 159,583.32 Form 4, filing 0000899243-18-012101
2018-05-07 Crispr Therapeutics AG
CRSP 		S, Open-market sale 2,862 disposed 50.31 143,987.22 Form 4, filing 0000899243-18-012101
2018-05-07 Crispr Therapeutics AG
CRSP 		S, Open-market sale 582 disposed 51.26 29,833.32 Form 4, filing 0000899243-18-012101
2018-05-07 Crispr Therapeutics AG
CRSP 		S, Open-market sale 249 disposed 51.26 12,763.74 Form 4, filing 0000899243-18-012101
2018-05-07 Crispr Therapeutics AG
CRSP 		S, Open-market sale 225 disposed 51.26 11,533.50 Form 4, filing 0000899243-18-012101
2018-04-30 Crispr Therapeutics AG
CRSP 		S, Open-market sale 26,860 disposed 50.29 1,350,789.40 Form 4, filing 0000899243-18-011133
2018-04-30 Crispr Therapeutics AG
CRSP 		S, Open-market sale 2,044 disposed 50.29 102,792.76 Form 4, filing 0000899243-18-011133
2018-04-30 Crispr Therapeutics AG
CRSP 		S, Open-market sale 874 disposed 50.26 43,927.24 Form 4, filing 0000899243-18-011133
2018-04-30 Crispr Therapeutics AG
CRSP 		S, Open-market sale 788 disposed 50.29 39,628.52 Form 4, filing 0000899243-18-011133
2018-04-27 Crispr Therapeutics AG
CRSP 		S, Open-market sale 10,236 disposed 50.02 512,004.72 Form 4, filing 0000899243-18-010983
2018-04-27 Crispr Therapeutics AG
CRSP 		S, Open-market sale 779 disposed 50.03 38,973.37 Form 4, filing 0000899243-18-010983
2018-04-27 Crispr Therapeutics AG
CRSP 		S, Open-market sale 333 disposed 50.01 16,653.33 Form 4, filing 0000899243-18-010983
2018-04-27 Crispr Therapeutics AG
CRSP 		S, Open-market sale 300 disposed 50.08 15,024.00 Form 4, filing 0000899243-18-010983
2018-04-26 Crispr Therapeutics AG
CRSP 		S, Open-market sale 185,075 disposed 50.11 9,274,108.25 Form 4, filing 0000899243-18-010983
2018-04-26 Crispr Therapeutics AG
CRSP 		S, Open-market sale 14,086 disposed 50.11 705,849.46 Form 4, filing 0000899243-18-010983
2018-04-26 Crispr Therapeutics AG
CRSP 		S, Open-market sale 6,019 disposed 50.12 301,672.28 Form 4, filing 0000899243-18-010983
2018-04-26 Crispr Therapeutics AG
CRSP 		S, Open-market sale 5,430 disposed 50.12 272,151.60 Form 4, filing 0000899243-18-010983
2018-04-24 Crispr Therapeutics AG
CRSP 		S, Open-market sale 20,071 disposed 51.00 1,023,621.00 Form 4, filing 0000899243-18-010841
2018-04-24 Crispr Therapeutics AG
CRSP 		S, Open-market sale 1,528 disposed 51.00 77,928.00 Form 4, filing 0000899243-18-010841
2018-04-24 Crispr Therapeutics AG
CRSP 		S, Open-market sale 653 disposed 51.00 33,303.00 Form 4, filing 0000899243-18-010841
2018-04-24 Crispr Therapeutics AG
CRSP 		S, Open-market sale 589 disposed 50.60 29,803.40 Form 4, filing 0000899243-18-010841
2018-04-23 Crispr Therapeutics AG
CRSP 		S, Open-market sale 89,628 disposed 50.66 4,540,554.48 Form 4, filing 0000899243-18-010683
2018-04-23 Crispr Therapeutics AG
CRSP 		S, Open-market sale 6,821 disposed 50.66 345,551.86 Form 4, filing 0000899243-18-010683
2018-04-23 Crispr Therapeutics AG
CRSP 		S, Open-market sale 2,915 disposed 51.00 148,665.00 Form 4, filing 0000899243-18-010683
2018-04-23 Crispr Therapeutics AG
CRSP 		S, Open-market sale 2,630 disposed 51.00 134,130.00 Form 4, filing 0000899243-18-010683
2017-12-22 Crispr Therapeutics AG
CRSP 		S, Open-market sale 3,059 disposed 20.29 62,070.47 Form 4, filing 0000899243-17-029615
2017-11-27 Crispr Therapeutics AG
CRSP 		S, Open-market sale 200 disposed 20.24 4,048.00 Form 4, filing 0000899243-17-027487
2017-11-24 Crispr Therapeutics AG
CRSP 		S, Open-market sale 1,700 disposed 20.21 34,357.85 Form 4, filing 0000899243-17-027487
2016-10-24 Crispr Therapeutics AG
CRSP 		P, Open-market purchase 95,596 acquired 14.00 1,338,344.00 Form 4, filing 0001104659-16-163805
2016-10-24 Crispr Therapeutics AG
CRSP 		P, Open-market purchase 60,219 acquired 14.00 843,066.00 Form 4, filing 0001104659-16-163805
2016-10-24 Crispr Therapeutics AG
CRSP 		P, Open-market purchase 4,583 acquired 14.00 64,162.00 Form 4, filing 0001104659-16-163805
2016-10-24 Crispr Therapeutics AG
CRSP 		P, Open-market purchase 602 acquired 14.00 8,428.00 Form 4, filing 0001104659-16-163805
2016-07-25 Audentes Therapeutics, Inc.
BOLD 		P, Open-market purchase 34,781 acquired 15.00 521,715.00 Form 4, filing 0001209191-16-133852
2016-07-25 Audentes Therapeutics, Inc.
BOLD 		P, Open-market purchase 219 acquired 15.00 3,285.00 Form 4, filing 0001209191-16-133852

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 10
  • Open-market sale 34
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Woiwode Thomas, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001619294

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.